Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

SnET2 photodynamic therapy stabilizes visual acuity in subfoveal choroidal neovascularization

May 11, 1999

Ocufit SR provides sustained release of diclofenac into the sclera

May 11, 1999

AGN-192024 is more effective than timolol in lowering IOP in patients with glaucoma

May 11, 1999

InSite Vision signs agreement with U. of California for glaucoma gene rights

May 4, 1999

Allergen patents new thromboxane receptor ligands with particular utility in ocular hypertension

May 3, 1999

Alcon to continue Lu-Tex development

April 27, 1999

Steroidogenesis inhibitor tested in mouse model of hereditary blindness

April 15, 1999

Eye implant receives FDA approval for correcting mild myopia

April 13, 1999

PhotoVision in-licenses novel technology for development of AMD treatment

April 7, 1999

Xalatan approved in Japan for glaucoma and ocular hypertension

March 16, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...